Increased levels of inflammatory markers, such as interleukin-(IL)-6 and C-reactive protein (CRP), predict the onset of poor health outcomes, particularly cardiovascular diseases and mortality [1, 2]. This evidence concerns the gene CRP and cardiovascular disorder.